# Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma

> **NCT00054808** · PHASE2 · COMPLETED · sponsor: **Genta Incorporated** · enrollment: 40 (—)

## Conditions studied

- Non-Hodgkin's Lymphoma
- Relapsed Lymphoma
- Refractory Lymphoma
- Low-Grade Lymphoma
- Intermediate-Grade Lymphoma

## Interventions

- **DRUG:** gallium nitrate

## Key facts

- **NCT ID:** NCT00054808
- **Lead sponsor:** Genta Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (—)
- **Last updated:** 2006-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00054808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00054808, "Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00054808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*